Malcolm R. Hill serves as Executive at Evoke Pharma Inc, where they oversee executive responsibilities. Since joining the company, Malcolm R. Hill has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 16, 2025 involved transacting 133 shares valued at $0.
Malcolm R. Hill currently holds 19,250 shares of Evoke Pharma Inc (EVOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Malcolm R. Hill has been a net neutral trader of EVOK stock. They have purchased $0 and sold $0 worth of shares.
Malcolm R. Hill's most recent insider trade was on Dec 16, 2025, when they sold 133 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.29 |
| Discretionary |